The company said its drugs will be more accessible than brand-name versions thanks to a partnership with a manufacturer of generic and 503B compounded injectables.
The company said its drugs will be more accessible than brand-name versions thanks to a partnership with a manufacturer of generic and 503B compounded injectables.